Nephcure Interview with Peter Mundel highlights Goldfinch Bio’s precision medicine approach to kidney disease

Goldfinch Bio founder and Senior Vice President of Biology Dr. Peter Mundel was recently featured in an interview by NephCure, an organization committed to support research seeking to improve understanding and treatments for kidney diseases that cause Nephrotic Syndrome.

Please click here to read the full interview.

In The NewsAdam Tebbe